Stephen Chanock: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Klb55 (talk | contribs)
mNo edit summary
Klb55 (talk | contribs)
m references
Line 8: Line 8:
'''Research activities'''
'''Research activities'''


Chanock co-leads several international consortial studies to identify and characterize the genetics of cancer susceptibility including [https://genomicsandhealth.org/work-products-demonstration-… BRCA Challenge], [http://epi.grants.cancer.gov/gameon/ Game-On], and the [http://epi.grants.cancer.gov/Consortia/cohort.html NCI Cohort Consortium]. His work focuses specifically on efforts to clarify the genetic architecture of cancer susceptibility<ref>{{Cite journal|last=Cerhan|first=James R.|last2=Berndt|first2=Sonja I.|last3=Vijai|first3=Joseph|last4=Ghesquières|first4=Hervé|last5=McKay|first5=James|last6=Wang|first6=Sophia S.|last7=Wang|first7=Zhaoming|last8=Yeager|first8=Meredith|last9=Conde|first9=Lucia|date=2014-11-01|title=Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma|url=https://www.ncbi.nlm.nih.gov/pubmed/25261932|journal=Nature Genetics|volume=46|issue=11|pages=1233–1238|doi=10.1038/ng.3105|issn=1546-1718|pmc=4213349|pmid=25261932}}</ref><ref>{{Cite journal|last=Wu|first=Chen|last2=Wang|first2=Zhaoming|last3=Song|first3=Xin|last4=Feng|first4=Xiao-Shan|last5=Abnet|first5=Christian C.|last6=He|first6=Jie|last7=Hu|first7=Nan|last8=Zuo|first8=Xian-Bo|last9=Tan|first9=Wen|date=2014-09-01|title=Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations|url=https://www.ncbi.nlm.nih.gov/pubmed/25129146|journal=Nature Genetics|volume=46|issue=9|pages=1001–1006|doi=10.1038/ng.3064|issn=1546-1718|pmc=4212832|pmid=25129146}}</ref>, the scope of genetic mosaicism and its contribution to cancer risk<ref>{{Cite journal|last=Jacobs|first=Kevin B.|last2=Yeager|first2=Meredith|last3=Zhou|first3=Weiyin|last4=Wacholder|first4=Sholom|last5=Wang|first5=Zhaoming|last6=Rodriguez-Santiago|first6=Benjamin|last7=Hutchinson|first7=Amy|last8=Deng|first8=Xiang|last9=Liu|first9=Chenwei|date=2012-06-01|title=Detectable clonal mosaicism and its relationship to aging and cancer|url=https://www.ncbi.nlm.nih.gov/pubmed/22561519|journal=Nature Genetics|volume=44|issue=6|pages=651–658|doi=10.1038/ng.2270|issn=1546-1718|pmc=3372921|pmid=22561519}}</ref><ref>{{Cite journal|last=Zhou|first=Weiyin|last2=Machiela|first2=Mitchell J.|last3=Freedman|first3=Neal D.|last4=Rothman|first4=Nathaniel|last5=Malats|first5=Nuria|last6=Dagnall|first6=Casey|last7=Caporaso|first7=Neil|last8=Teras|first8=Lauren T.|last9=Gaudet|first9=Mia M.|date=2016-05-01|title=Mosaic loss of chromosome Y is associated with common variation near TCL1A|url=https://www.ncbi.nlm.nih.gov/pubmed/27064253|journal=Nature Genetics|volume=48|issue=5|pages=563–568|doi=10.1038/ng.3545|issn=1546-1718|pmc=4848121|pmid=27064253}}</ref>, and how germline variation informs our understanding of somatic alterations in cancer<ref>{{Cite journal|last=Machiela|first=Mitchell J.|last2=Ho|first2=Brian M.|last3=Fisher|first3=Victoria A.|last4=Hua|first4=Xing|last5=Chanock|first5=Stephen J.|date=2015-01-01|title=Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571124/|journal=Genome Biology|volume=16|issue=1|doi=10.1186/s13059-015-0755-5|issn=1474-7596|pmc=4571124|pmid=26374197}}</ref><ref>{{Cite journal|last=Wang|first=Zhaoming|last2=Rajaraman|first2=Preetha|last3=Melin|first3=Beatrice S.|last4=Chung|first4=Charles C.|last5=Zhang|first5=Weijia|last6=McKean-Cowdin|first6=Roberta|last7=Michaud|first7=Dominique|last8=Yeager|first8=Meredith|last9=Ahlbom|first9=Anders|date=2015-07-01|title=Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750473/|journal=Human mutation|volume=36|issue=7|pages=684–688|doi=10.1002/humu.22799|issn=1059-7794|pmc=4750473|pmid=25907361}}</ref>.
Chanock co-leads several international consortial studies to identify and characterize the genetics of cancer susceptibility including [https://genomicsandhealth.org/work-products-demonstration-… BRCA Challenge], [http://epi.grants.cancer.gov/gameon/ Game-On], and the [http://epi.grants.cancer.gov/Consortia/cohort.html NCI Cohort Consortium]. His work focuses specifically on efforts to clarify of the scope of genetic mosaicism and its contribution to cancer risk<sup>3,4</sup>, the genetic architecture of cancer susceptibility<sup>5-7</sup>, and how germline variation informs our understanding of somatic alterations in cancer.


'''Awards'''
'''Awards'''

Revision as of 19:22, 21 September 2016

Stephen Jacob Chanock (born April 15, 1966) is an American physician and geneticist. He currently serves as Director of the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute (NCI)1.  

Biography

Chanock completed undergraduate studies at Princeton University in 1978, and his medical training at Harvard Medical School in 1983. He completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston, MA. He has held multiple positions, both in research and scientific leadership over his career at the NCI1. Since 1995, Chanock has served as the Medical Director for Camp Fantastic, a week-long recreational camp for pediatric cancer patients2. He has received numerous awards for his work in the discovery and characterization of cancer susceptibility regions in the human genome. These include the Niehaus, Southorth, Weissenbach Award in Clinical Cancer Genetics. Chanock is an elected member of Association of American Physicians, the American Epidemiology Society and the Society for Pediatric Research. He is the author of over 900 publications and dozens of book chapters.

Research activities

Chanock co-leads several international consortial studies to identify and characterize the genetics of cancer susceptibility including BRCA Challenge, Game-On, and the NCI Cohort Consortium. His work focuses specifically on efforts to clarify the genetic architecture of cancer susceptibility[1][2], the scope of genetic mosaicism and its contribution to cancer risk[3][4], and how germline variation informs our understanding of somatic alterations in cancer[5][6].

Awards

  • Association of American Physicians (elected 2013)
  • American Epidemiology Society (elected 2013)
  • Society for Pediatric Research (elected 1998)

References

1.    http://dceg.cancer.gov/about/staff-directory/biographies/O-Z/chanock-stephen

2.    http://specialove.org/camps/patients-survivors/camp-fantastic/

3.     Zhou W, Machiela MJ, Freedman ND, Rothman N, Malats N, Dagnall C, Caporaso N, Teras LT, Gaudet MM, Gapstur SM, Stevens VL, Jacobs KB, Sampson J, Albanes D, Weinstein S, Virtamo J, Berndt S, Hoover RN, Black A, Silverman D, Figueroa J, Garcia-Closas M, Real FX, Earl J, Marenne G, Rodriguez-Santiago B, Karagas M, Johnson A, Schwenn M, Wu X, Gu J, Ye Y, Hutchinson A, Tucker M, Perez-Jurado LA, Dean M, Yeager M, Chanock SJ.  Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet. 2016 May;48(5):563-8. doi: 10.1038/ng.3545. Epub 2016 Apr 11.

4.     Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, Taylor PR, Freedman ND, Abnet CC, Goldstein AM, Hu N, Yu K, Yuan JM, Liao L, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Aldrich MC, Amos C, Blot WJ, Bock CH, Gillanders EM, Harris CC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, McNeill LH, Rybicki BA, Schwartz AG, Signorello LB, Spitz MR, Wiencke JK, Wrensch M, Wu X, Zanetti KA, Ziegler RG, Figueroa JD, Garcia-Closas M, Malats N, Marenne G, Prokunina-Olsson L, Baris D, Schwenn M, Johnson A, Landi MT, Goldin L, Consonni D, Bertazzi PA, Rotunno M, Rajaraman P, Andersson U, Freeman LE, Berg CD, Buring JE, Butler MA, Carreon T, Feychting M, Ahlbom A, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Hartge P, Henriksson R, Inskip PD, Johansen C, Landgren A, McKean-Cowdin R, Michaud DS, Melin BS, Peters U, Ruder AM, Sesso HD, Severi G, Shu XO, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Silverman DT, Kogevinas M, Gonzalez JR, Villa O, Li D, Duell EJ, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Hassan M, Wheeler W, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross MD, Holly EA, Klein AP, Lacroix A, Mandelson MT, Petersen G, Boutron-Ruault MC, Bracci PM, Canzian F, Chang K, Cotterchio M, Giovannucci EL, Goggins M, Bolton JA, Jenab M, Khaw KT, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Rabe KG, Riboli E, Tjonneland A, Tobias GS, Trichopoulos D, Elena JW, Yu H, Amundadottir L, Stolzenberg-Solomon RZ, Kraft P, Schumacher F, Stram D, Savage SA, Mirabello L, Andrulis IL, Wunder JS, Garcia AP, Sierrasesumaga L, Barkauskas DA, Gorlick RG, Purdue M, Chow WH, Moore LE, Schwartz KL, Davis FG, Hsing AW, Berndt SI, Black A, Wentzensen N, Brinton LA, Lissowska J, Peplonska B, McGlynn KA, Cook MB, Graubard BI, Kratz CP, Greene MH, Erickson RL, Hunter DJ, Thomas G, Hoover RN, Real FX, Fraumeni JF, Jr., Caporaso NE, Tucker M, Rothman N, Perez-Jurado LA*, Chanock SJ*. Detectable Clonal Mosaicism and Its Relationship to Aging and Cancer. Nat Genet 2012;44(6):651-658.

5.     Cerhan JR, Berndt SI, Vijai J, Ghesquières H, McKay J, Wang SS, Wang Z, Yeager M, Conde L, de Bakker PI, Nieters A, Cox D, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Lan Q, Severi G, Melbye M, Gu J, Jackson RD, Kane E, Teras LR, Purdue MP, Vajdic CM, Spinelli JJ, Giles GG, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Weiner GJ, Veron AS, Zelenika D, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Kricker A, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Vermeulen RC, Boeing H, Tjonneland A, Angelucci E, Di Lollo S, Rais M, Birmann BM, Laden F, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Sampson J, Liang L, Park JH, Chung CC, Weisenburger DD, Chatterjee N, Fraumeni JF Jr, Slager SL, Wu X, de Sanjose S, Smedby KE, Salles G, Skibola CF, Rothman N, Chanock SJ.  Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014 Nov;46(11):1233-8

6.     Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, Hu N, Zuo XB, Tan W, Zhan Q, Hu Z, He Z, Jia W, Zhou Y, Yu K, Shu XO, Yuan JM, Zheng W, Zhao XK, Gao SG, Yuan ZQ, Zhou FY, Fan ZM, Cui JL, Lin HL, Han XN, Li B, Chen X, Dawsey SM, Liao L, Lee MP, Ding T, Qiao YL, Liu Z, Liu Y, Yu D, Chang J, Wei L, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Han JJ, Zhou SL, Zhang P, Zhang DY, Yuan Y, Huang Y, Liu C, Zhai K, Qiao Y, Jin G, Guo C, Fu J, Miao X, Lu C, Yang H, Wang C, Wheeler WA, Gail M, Yeager M, Yuenger J, Guo ET, Li AL, Zhang W, Li XM, Sun LD, Ma BG, Li Y, Tang S, Peng XQ, Liu J, Hutchinson A, Jacobs K, Giffen C, Burdette L, Fraumeni JF Jr, Shen H, Ke Y, Zeng Y, Wu T, Kraft P, Chung CC, Tucker MA, Hou ZC, Liu YL, Hu YL, Liu Y, Wang L, Yuan G, Chen LS, Liu X, Ma T, Meng H, Sun L, Li XM, Li XM, Ku JW, Zhou YF, Yang LQ, Wang Z, Li Y, Qige Q, Yang WJ, Lei GY, Chen LQ, Li EM, Yuan L, Yue WB, Wang R, Wang LW, Fan XP, Zhu FH, Zhao WX, Mao YM, Zhang M, Xing GL, Li JL, Han M, Ren JL, Liu B, Ren SW, Kong QP, Li F, Sheyhidin I, Wei W, Zhang YR, Feng CW, Wang J, Yang YH, Hao HZ, Bao QD, Liu BC, Wu AQ, Xie D, Yang WC, Wang L, Zhao XH, Chen SQ, Hong JY, Zhang XJ, Freedman ND, Goldstein AM, Lin D, Taylor PR, Wang LD, Chanock SJ.  Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet. 2014 Sep;46(9):1001-6.

7.     Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, Barkauskas DA, Marina N, de Toledo SR, Petrilli AS, Amary MF, Halai D, Thomas DM, Douglass C, Meltzer PS, Jacobs K, Chung CC, Berndt SI, Purdue MP, Caporaso NE, Tucker M, Rothman N, Landi MT, Silverman DT, Kraft P, Hunter DJ, Malats N, Kogevinas M, Wacholder S, Troisi R, Helman L, Fraumeni JF Jr, Yeager M, Hoover RN, Chanock SJ. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 2013;45(7):799-803


  1. ^ Cerhan, James R.; Berndt, Sonja I.; Vijai, Joseph; Ghesquières, Hervé; McKay, James; Wang, Sophia S.; Wang, Zhaoming; Yeager, Meredith; Conde, Lucia (2014-11-01). "Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma". Nature Genetics. 46 (11): 1233–1238. doi:10.1038/ng.3105. ISSN 1546-1718. PMC 4213349. PMID 25261932.
  2. ^ Wu, Chen; Wang, Zhaoming; Song, Xin; Feng, Xiao-Shan; Abnet, Christian C.; He, Jie; Hu, Nan; Zuo, Xian-Bo; Tan, Wen (2014-09-01). "Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations". Nature Genetics. 46 (9): 1001–1006. doi:10.1038/ng.3064. ISSN 1546-1718. PMC 4212832. PMID 25129146.
  3. ^ Jacobs, Kevin B.; Yeager, Meredith; Zhou, Weiyin; Wacholder, Sholom; Wang, Zhaoming; Rodriguez-Santiago, Benjamin; Hutchinson, Amy; Deng, Xiang; Liu, Chenwei (2012-06-01). "Detectable clonal mosaicism and its relationship to aging and cancer". Nature Genetics. 44 (6): 651–658. doi:10.1038/ng.2270. ISSN 1546-1718. PMC 3372921. PMID 22561519.
  4. ^ Zhou, Weiyin; Machiela, Mitchell J.; Freedman, Neal D.; Rothman, Nathaniel; Malats, Nuria; Dagnall, Casey; Caporaso, Neil; Teras, Lauren T.; Gaudet, Mia M. (2016-05-01). "Mosaic loss of chromosome Y is associated with common variation near TCL1A". Nature Genetics. 48 (5): 563–568. doi:10.1038/ng.3545. ISSN 1546-1718. PMC 4848121. PMID 27064253.
  5. ^ Machiela, Mitchell J.; Ho, Brian M.; Fisher, Victoria A.; Hua, Xing; Chanock, Stephen J. (2015-01-01). "Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation". Genome Biology. 16 (1). doi:10.1186/s13059-015-0755-5. ISSN 1474-7596. PMC 4571124. PMID 26374197.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Wang, Zhaoming; Rajaraman, Preetha; Melin, Beatrice S.; Chung, Charles C.; Zhang, Weijia; McKean-Cowdin, Roberta; Michaud, Dominique; Yeager, Meredith; Ahlbom, Anders (2015-07-01). "Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data". Human mutation. 36 (7): 684–688. doi:10.1002/humu.22799. ISSN 1059-7794. PMC 4750473. PMID 25907361.